貴州三力(603439.SH)擬斥2.32億元投資德昌祥獲其95%股權
格隆匯2月6日丨貴州三力(603439.SH)公佈,公司分析認為“德昌祥”品牌為百年老字號,具備較大的影響力,其前身為貴陽中藥廠,具有眾多優質藥品批文。公司投資貴陽德昌祥藥業有限公司(簡稱“德昌祥”)是基於拓展產品種類,解決公司產品相對集中的風險,提升公司行業競爭力,促進公司長遠、健康發展的戰略發展角度考慮,成為德昌祥的破產重整投資人,對公司市場競爭發展能力具有積極意義。此次重整公司擬一次性出資2.32億元取得德昌祥95%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.